Spinal Cord Injury (SCI)
Neurology·MeSH: Spinal Cord Injuries
Prevalence
30.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Elezanumab | AbbVie Inc. (ABBV) |
Frequently asked questions
How many drugs are in development for Spinal Cord Injury (SCI)?
BioSniper tracks 1 drug in development for Spinal Cord Injury (SCI) across 1 company.
How many clinical trials target Spinal Cord Injury (SCI)?
There are 1 clinical trial targeting Spinal Cord Injury (SCI) tracked by BioSniper.
What is the prevalence of Spinal Cord Injury (SCI)?
The estimated prevalence of Spinal Cord Injury (SCI) is approximately 30.0 per 100,000 population.
Deep-dive into Spinal Cord Injury (SCI)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis